Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 03 2019
Historique:
received: 10 09 2018
accepted: 01 02 2019
entrez: 7 3 2019
pubmed: 7 3 2019
medline: 24 9 2020
Statut: epublish

Résumé

Post-pubertal testicular germ-cell tumours (TGCTs) can present with a variety of distinct histologies which are nevertheless lineage related and often co-occurring. The exact lineage relationships and developmental pathways leading to the different histologies is debated. In order to investigate the relationship of histologic populations, mate-pair sequencing (MPseq) and exome sequencing (ExomeSeq) were conducted on different histological populations within the same tumour. Ten TGCTs with 1-3 histologic types/tumour were sequenced. Junctions of somatic chromosomal rearrangements were identified on a per genome basis, with germ cell neoplasia in situ possessing the least (median 1, range 0-4) and embryonal carcinoma the most (median 8.5, range 6-12). Copy number variation revealed gains and losses, including isoform 12p (i12p) (10/10 samples), and chromosomes 7, 8, and 21 gains (7/10 samples). Mapping of shared junctions within a tumour revealed lineage relationships, but only i12p was shared between patients. ExomeSeq from two cases demonstrated a high level of copy-neutral loss of heterozygosity. Parallel assessment of separate histologies within a single TGCT demonstrated cumulative and divergent changes, suggesting the importance of parallel sequencing for detection of relevant biomarkers.

Identifiants

pubmed: 30837548
doi: 10.1038/s41598-019-39956-y
pii: 10.1038/s41598-019-39956-y
pmc: PMC6400951
doi:

Substances chimiques

DNA, Neoplasm 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3586

Références

Bioinformatics. 2018 May 15;34(10):1629-1634
pubmed: 29281001
Am J Pathol. 2004 Jan;164(1):305-13
pubmed: 14695343
Cancer Genet. 2018 Feb;221:1-18
pubmed: 29405991
Hum Pathol. 2019 Feb;84:71-80
pubmed: 30266250
Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):359-67
pubmed: 17993720
Cancer Res. 2014 Jun 1;74(11):3157-67
pubmed: 24879567
DNA Res. 2012 Oct;19(5):395-406
pubmed: 22991452
Nat Commun. 2015 Jan 22;6:5973
pubmed: 25609015
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Cell Rep. 2018 Jun 12;23(11):3392-3406
pubmed: 29898407
Genes Chromosomes Cancer. 2002 Jun;34(2):168-74
pubmed: 11979550
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Bioinformatics. 2014 Jun 1;30(11):1627-9
pubmed: 24526710
Am J Cancer Res. 2012;2(2):153-67
pubmed: 22432056
Cancer Res. 2005 Sep 15;65(18):8085-9
pubmed: 16166280
Nature. 2016 Nov 30;540(7631):114-118
pubmed: 27905446
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369
pubmed: 29632055
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Hum Pathol. 2017 Jan;59:10-25
pubmed: 27569298
Urology. 2012 Aug;80(2):485.e1-5
pubmed: 22503760
Radiographics. 2004 Mar-Apr;24(2):387-404
pubmed: 15026588
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Surg Pathol Clin. 2015 Dec;8(4):687-716
pubmed: 26612222
N Engl J Med. 2014 Nov 20;371(21):2005-16
pubmed: 25409373
Lancet. 2016 Apr 23;387(10029):1762-74
pubmed: 26651223
Curr Opin Urol. 2017 Jan;27(1):41-47
pubmed: 27584029
Int J Androl. 2007 Aug;30(4):337-48; discussion 349
pubmed: 17573850
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
APMIS. 1998 Jan;106(1):90-9; discussion 99-100
pubmed: 9524567
Nat Rev Cancer. 2003 Jul;3(7):517-25
pubmed: 12835671
Lancet. 2006 Mar 4;367(9512):754-65
pubmed: 16517276
Genes Chromosomes Cancer. 2018 Sep;57(9):459-470
pubmed: 29726617
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
J Clin Oncol. 2014 Dec 20;32(36):4050-8
pubmed: 25385739
Cancer Res. 2013 Jun 1;73(11):3275-84
pubmed: 23695551
Cancer Genomics Proteomics. 2016 Jul-Aug;13(4):281-9
pubmed: 27365378
Bioinformatics. 2014 Jul 1;30(13):1920-2
pubmed: 24618464
Int J Biochem Cell Biol. 2017 May;86:22-25
pubmed: 28288913
J Natl Compr Canc Netw. 2012 Apr;10(4):502-35
pubmed: 22491049
J Assoc Genet Technol. 2018;44(4):128-133
pubmed: 30533005
Hum Pathol. 2013 Oct;44(10):2312-22
pubmed: 23938161

Auteurs

Alan H Bryce (AH)

Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA. bryce.alan@mayo.edu.
Mayo Clinic Cancer Center, Phoenix, Arizona, USA. bryce.alan@mayo.edu.
Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA. bryce.alan@mayo.edu.

Jan B Egan (JB)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

James B Smadbeck (JB)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Sarah H Johnson (SH)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Stephen J Murphy (SJ)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Faye R Harris (FR)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Geoffrey C Halling (GC)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Simone B S P Terra (SBSP)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

John Cheville (J)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Lance Pagliaro (L)

Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Brad Leibovich (B)

Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.

Brian A Costello (BA)

Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

George Vasmatzis (G)

Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH